1-(4-(Trifluoromethyl)phenyl)piperazine
-piperazine.svg.png.webp) | |
| Clinical data | |
|---|---|
| Other names | N-(para-[Trifluoromethyl)phenyl]piperazine, 1-(α,α,α-Trifluoro-p-tolyl)piperazine |
| Pharmacokinetic data | |
| Bioavailability | Unknown |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.631 |
| Chemical and physical data | |
| Formula | C11H13F3N2 |
| Molar mass | 230.234 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
 N Y (what is this?) | |
1-[4-(Trifluoromethyl)phenyl]piperazine (pTFMPP) is a serotonergic releasing agent. It is rarely encountered as a designer drug but is much less common than the "normal" isomer meta-TFMPP.[1]
See also
References
- ↑ "BZP and other piperazines". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2010.
Serotonin receptor modulators | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 |
| ||||||||||||||||||||||||||||||||||||||
| 5-HT2 |
| ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 |
| ||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.